Ricardo Mesquita Camelo

Universidade Federal de Minas Gerais — Brazil

Medicine · Health Sciences

7h-index120citations64works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(47), Platelet Disorders and Treatments(13), Coagulation, Bradykinin, Polyphosphates, and Angioedema(9), Blood Coagulation and Thrombosis Mechanisms(7), Cancer-related gene regulation(6)

Publications64 total

Custos do Emicizumabe na Hemofilia A: Comparação entre Despesas Pós-Incorporação e Projeções Governamentais no Brasil
Jornal de Assistência Farmacêutica e Farmacoeconomia·2026Open Access
Monitoramento do Horizonte Tecnológico de novas terapias para hemofilia A no Brasil
Jornal de Assistência Farmacêutica e Farmacoeconomia·2026Open Access
Factor-VIII mimetic bispecific antibodies for the treatment of hemophilia A: an update.
PubMed·2026
Gene therapy in the treatment of hemophilia A: a systematic review and meta-analysis
Expert Review of Hematology·2026
Gene therapy in the treatment of hemophilia A: a systematic review and meta-analysis
Figshare·2026Open Access
Gene therapy in the treatment of hemophilia A: a systematic review and meta-analysis
Figshare·2026Open Access
Corrigendum to ‘Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors’
Research and Practice in Thrombosis and Haemostasis·2026Open Access
PD87 Costs of Emicizumab in Hemophilia A: Comparison Between Post-Incorporation Expenses and Government Projections in Brazil
International Journal of Technology Assessment in Health Care·2025Open Access
ID 350 - Efetividade Clínica e Custos do Emicizumabe para Hemofilia A: avaliação de desempenho pós-incorporação
Europe PMC (PubMed Central)·2025Open Access
Public health assistance for people with haemophilia in Brazil (PATCH study): a cross-sectional study protocol
BMJ Open·2025Open Access
Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Genomic ancestry, F8 variants, and immune tolerance in hemophilia A patients with inhibitors: exome sequencing insights
Haematologica·2025Open Access
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study
Thrombosis Research·2025
Terapia Gênica no Tratamento da Hemofilia A: uma revisão sistemática
Epidemiologia e Serviços de Saúde·2025Open Access
PD10 Cost Effectiveness Analysis Of Etranacogene Dezaparvovec Versus Factor IX Prophylaxis In Adult Men With Hemophilia B From Brazil
International Journal of Technology Assessment in Health Care·2024Open Access
Análise de desempenho do emicizumabe no tratamento da hemofilia a no brasil: resultados do primeiro ano de acompanhamento do registro brasileiro de emicizumabe (Projeto EMCase)
Jornal de Assistência Farmacêutica e Farmacoeconomia·2024Open Access
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model
Research and Practice in Thrombosis and Haemostasis·2024Open Access
Minor surgical procedures during immune tolerance induction in people with hemophilia A and inhibitors: results from the Brazilian Immune Tolerance (BrazIT) study cohort
Hematology Transfusion and Cell Therapy·2024Open Access
Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors
Thrombosis Research·2024· 3 cited
page 1 of 4Next →

Frequent Co-authors

Suely Meireles Rezende(18), Daniel Gonçalves Chaves(11), Juliana Álvares-Teodoro(10), Luciana W. Zuccherato(9), Vivian Karla Brognoli Franco(9), Maria do Rosário Ferraz Roberti(8), Claúdia Santos Lorenzato(8), Andrea Gonçalves de Oliveira(7), Leina Yukari Etto(7), M. Cerqueira(7), Íris Maciel Costa(7), Tânia Maria Rocha Guimarães(7), Samantha C. Gouw(6), Maíse Moreira Dias(6), Letícia Lemos Jardim(6), Fábia Michelle Rodrigues de Araújo Callado(6), T Anegawa(6), Ana Maria Vanderlei(6), Roberto Lúcio Muniz(5), Francisco de Assis Acúrcio(5)